Heparin – An old drug with multiple potential targets in Covid‐19 therapy

Saved in:
Bibliographic Details
Published inJournal of thrombosis and haemostasis Vol. 18; no. 9; pp. 2422 - 2424
Main Authors Lindahl, Ulf, Li, Jin‐Ping
Format Journal Article
LanguageEnglish
Published England Elsevier Limited 01.09.2020
John Wiley and Sons Inc
Subjects
Anticoagulants
Anticoagulants - therapeutic use
COVID-19
COVID-19 - drug therapy
Critical Illness
Glycosaminoglycans - chemistry
Heparin
Heparin - therapeutic use
Heparitin Sulfate - chemistry
Humans
Inflammation
Letter to the Editor
Letters to the Editor
Protein Binding
Pulmonary Gas Exchange
Sepsis - complications
Online AccessGet full text

Cover

More Information
Bibliography:Final decision: David Lillicrap, 13 May 2020
Manuscript handled by: David Lillicrap
SourceType-Scholarly Journals-1
content type line 14
ObjectType-Editorial-2
ObjectType-Commentary-1
ObjectType-Article-2
ObjectType-Correspondence-1
content type line 23
ISSN:1538-7933
1538-7836
1538-7836
DOI:10.1111/jth.14898